Pharmaceutical Company Preemptively Files Free Speech Suit Against The FDA
By: Nawa Arsala Free speech is fundamental to the fabric of the United States. Americans fight for it zealously, regardless of the context, from political contributions to cartoon drawing contests. This battle has extended to the pharmaceutical industry. In an unconventional move, a small, Dublin-based pharmaceutical company, Amarin, filed suit […]
Empowering the Global Health System
In March 2014, the largest Ebola epidemic in history broke out in West Africa. It rapidly spread over the region, killing over 10,000 individuals since being declared an international public health concern in August. While projections suggest that the epidemic will end during 2015, there is still a desperate need […]
Supreme Court Declines To Hear Appeal Challenging the Independent Payment Advisory Board
By: Stuart I. Silverman, Esq. On March 30, 2015, the U.S. Supreme Court declined to grant a writ of certiorari in an appeal of the Ninth Circuit’s decision in Nick Coons and Eric N. Novack, M.D. v. Jacob L. Lew, et al.,[i] rendered by the appellate court on August 7, […]
Herbal Supplement Industry Under Fire – Part II
On Monday, March 30, GNC reached an agreement with the New York Attorney General requiring testing standards for their “Herbal Plus” supplements that exceed current Food and Drug Administration (FDA) requirements. This agreement comes almost two months after the NY Attorney General sent letters to GNC, Walmart, Walgreens, and Target […]
Supreme Court Argues Over Health Law Subsidies
On March 4, 2015, the Supreme Court participated in a divided and heated argument addressing the issue of whether the Internal Revenue Service (IRS) may permissibly promulgate regulations to extend tax-credit subsidies to coverage purchased through exchanges established by the federal government under Section 1321 of the Patient Protection and […]